for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Sino Biopharmaceutical Limited

1177.HK

Latest Trade

11.48HKD

Change

-0.08(-0.69%)

Volume

20,339,014

Today's Range

11.34

 - 

11.70

52 Week Range

5.86

 - 

12.50

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Sino Biopharmaceutical Announces Proposed Issue Of Euro 750 Mln Zero Coupon Convertible Bonds Due 2025

Jan 23 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::ANNOUNCES PROPOSED ISSUE OF EURO 750 MILLION ZERO COUPON- CONVERTIBLE BONDS DUE 2025.

Sino Biopharmaceutical Says Drug For Treatment Of Osteoarthritis Passes Consistency Evaluation

Jan 21 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::UNIT'S MEDICINE FOR TREATMENT OF OSTEOARTHRITIS GETS NOD FOR CONSISTENCY EVALUATION.

Sino Biopharmaceutical's Unit Entered Into Distribution Agreement With Octapharma AG

Jan 21 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::UNIT ENTERED INTO A DISTRIBUTION AGREEMENT WITH OCTAPHARMA AG.UNDER DEAL, NANJING CHIA TAI WILL ACT AS EXCLUSIVE DISTRIBUTOR IN PRC OF HUMAN ALBUMIN PRODUCTS PRODUCED BY OCTAPHARMA.

Sino Biopharmaceutical Updates on "Edaravone And Sodium Chloride Injection"

Jan 14 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::"EDARAVONE AND SODIUM CHLORIDE INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION.

Sino Biopharmaceutical Says Celecoxib Capsule Obtains Approval For Drug Registration

Jan 9 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::CELECOXIB CAPSULE DEVELOPED BY UNIT OBTAINED APPROVAL FOR DRUG REGISTRATION GRANTED BY NMPA OF PEOPLE'S REPUBLIC OF CHINA.

Sino Biopharmaceutical Says "Fosaprepitant For Injection" Obtained Marketing Authorization Issued By European Union

Jan 8 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::"FOSAPREPITANT FOR INJECTION" OBTAINED MARKETING AUTHORIZATION ISSUED BY EUROPEAN UNION.GROUP HAS ENTERED INTO AGREEMENTS WITH EUROPEAN UNION SALES PARTNERS TO LAUNCH PRODUCT IN EU IN FIRST HALF OF 2020.

Sino Biopharmaceutical Says Antithrombotic Drug "Ticagrelor Tablet" Developed By Unit Obtained Approval For Drug Registration By NMPA

Dec 20 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::ANTITHROMBOTIC DRUG "TICAGRELOR TABLET" DEVELOPED BY UNIT OBTAINED APPROVAL FOR DRUG REGISTRATION BY NMPA OF PRC.

Sino Biopharmaceutical Says Unit's 'Bortezomib For Injection' Gets Approval Of Drug Supplementary Application

Dec 16 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::UNIT'S 'BORTEZOMIB FOR INJECTION' GETS APPROVAL OF DRUG SUPPLEMENTARY APPLICATION FROM NMPA OF PRC.

Sino Biopharmaceutical Says Argatroban Injection Obtains Approval By NMPA Of PRC

Dec 12 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::ARGATROBAN INJECTION, DEVELOPED BY UNIT HAS OBTAINED APPROVAL FOR DRUG REGISTRATION GRANTED BY NMPA OF PRC.

Sino Biopharmaceutical "Bendamustine Hydrochloride For Injection" Approved For Drug Registration

Dec 11 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::"BENDAMUSTINE HYDROCHLORIDE FOR INJECTION" APPROVED FOR DRUG REGISTRATION BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up